Veraxa Biotech is trading at $1.20, up 5.26% after hours, with no clear company-specific catalyst identified.

  • The after-hours gain follows a 9.52% decline during the regular session from its October 12, 2026 close of $1.14.
  • Available coverage reported no October 12 headlines; the latest identified company release was dated October 7, and the World ADC Congress began October 12. Neither was reported as causing the move.